Maggie Flanagan LeFlore
Geen lopende functies
Loopbaan van Maggie Flanagan LeFlore
Eerdere bekende functies van Maggie Flanagan LeFlore
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
MedImmune Ventures, Inc.
 MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland. | Private Equity Investor | 01-06-2007 | 30-03-2010 |
| ASTRIA THERAPEUTICS, INC. | Directeur/Bestuurslid | 23-04-2010 | - |
NKT Therapeutics, Inc.
 NKT Therapeutics, Inc. BiotechnologyHealth Technology NKT Therapeutics, Inc. operates as a biotechnology company. It focuses on developing therapeutics based on unique immune cells called natural killer NKT cells. The company was founded by Alem Truneh, S. Brian Wilson, Mark Exley, Steve K. Balk, and Mark A. Tepper on November 20, 2008 and is headquartered in Waltham, MA. | Directeur/Bestuurslid | 27-11-2009 | - |
Opleiding van Maggie Flanagan LeFlore
| Indiana University | Doctorate Degree |
| University of Kansas | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 6 |
Operationeel
| Director/Board Member | 2 |
| Private Equity Investor | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Consumer Services | 3 |
| Health Technology | 3 |
| Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ASTRIA THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
MedImmune Ventures, Inc.
MedImmune Ventures, Inc. Investment ManagersFinance MedImmune Ventures, Inc. ( Medimmune Ventures) is a venture capital firm founded in 2002 by Ron Laufer, Wayne Hockmeyer and David Mott . The firm is headquartered in Gaithersburg, Maryland. | Finance |
NKT Therapeutics, Inc.
NKT Therapeutics, Inc. BiotechnologyHealth Technology NKT Therapeutics, Inc. operates as a biotechnology company. It focuses on developing therapeutics based on unique immune cells called natural killer NKT cells. The company was founded by Alem Truneh, S. Brian Wilson, Mark Exley, Steve K. Balk, and Mark A. Tepper on November 20, 2008 and is headquartered in Waltham, MA. | Health Technology |
